by Bruce Sylvester – Investigators suggest caution in prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, after their research shows a twofold risk for repeat infection.
by Bruce Sylvester – Research presented on September 26, 2013 the European Association for the Study of Diabetes (EASD) annual meeting in Barcelona, Spain, indicates that type 2… read more.
by Bruce Sylvester – Alogliptin treatment of patients with type 2 diabetes and with high cardiovascular risk due to recent acute coronary syndromes has led to similar rates… read more.
by Bruce Sylvester – Researchers report that, after a decade when prescription opioid use has grown dramatically, identification and treatment of pain has not improved, and, notably, the… read more.
‘Big 4’ Journal Highlights – New England Journal of Medicine (NEJM) – by Bruce Sylvester – Research published on Aug. 7, 2013 in the New England Journal of Medicine/NEJM indicates… read more.
‘Big 4’ Journal Highlights – The Lancet – by Bruce Sylvester – Opioid dependence leads in causing death and illness among all illicitly used drugs, researchers report. The… read more.
‘Big 4’ Journal Highlights – Journal of the American Medical (JAMA) – by Bruce Sylvester -Among patients with unfavorable treatment characteristics, treating chronic hepatitis C virus (HCV) genotype… read more.
‘Big 4’ Journal Highlights – British Medical Journal (BMJ) – by Bruce Sylvester – Children of obese mothers are more likely to die before age 55 than children… read more.
FDA Highlights by Bruce Sylvester – Researchers report that, in a double-blind trial involving clinically depressed patients who had not responded to at least three prior antidepressants, intravenous… read more.
FDA Highlights by Bruce Sylvester – Treatment with the antipsycotic drug haloperidol does not reduce symptoms of delirium in critically ill patients, UK researchers report.
FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.
FDA Highlights by Bruce Sylvester – Misoprostol vaginal insert used for labor induction has significantly reduced time to vaginal delivery compared with dinoprostone vaginal insert, researchers reported at… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
